
Valerie K Arnold MD DFAPA, DFAACAP, ACPsych
Child & Adolescent Psychiatry
Chief Child and Adolescent Psychiatry University of Tennessee Health Science Center College of Medicine/ Principal Investigator-CNS Healthcare
Join to view full profile
1910 Nonconnah BlvdSte 120Memphis, TN 38132
Phone+1 901-448-2300
Fax+1 901-448-6657
Dr. Arnold is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Valerie Arnold is a psychiatrist in Memphis, TN and is affiliated with multiple hospitals in the area, including Le Bonheur Children's Hospital, Parkwood Behavioral Health System, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Methodist Healthcare Memphis Hospitals, and St. Jude Children's Research Hospital. She received her medical degree from University of Alabama School of Medicine and has been in practice 33 years. She specializes in child & adolescent psychiatry and is experienced in learning disorders, attention-deficit/hyperactivity disorder, and clinical research. She has more than 100 publications and over 500 citings.
Education & Training
University of TennesseeFellowship, Child and Adolescent Psychiatry, 1991 - 1993
University of Tennessee College of MedicineResidency, Psychiatry, 1988 - 1991
University of Alabama School of MedicineClass of 1988
Tulane UniversityB.S., Biology and Visual Communication, 1980
Certifications & Licensure
TN State Medical License 1989 - 2028
MS State Medical License 1998 - 2027
AL State Medical License 1999 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Awards, Honors, & Recognition
- Best Doctor Commerial Appeal Newspaper Poll, 2012
- Teaching Award UTHSC Department of Psychiatry, 2012
- Co-Chief Fellows of the Child and Adolescent Psychiatry Fellowship UTHSC, 1993
Clinical Trials
- Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) Start of enrollment: 2011 Jan 17
- Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- 1 citationsA phase 2, multicenter, double-blind, randomized, placebo-controlled study of the safety and efficacy of forvisirvat (SP-624) in the treatment of adults with major dep...Joel Raskin, Anita H Clayton, Susan G Kornstein, George I Papakostas, Yuki Prescott
Current Medical Research and Opinion. 2025-09-01 - 2 citationsTikTok Challenges-Unintentional Injuries vs Suicide Attempts.Onomeasike Ataga, Valerie K Arnold
JAMA Psychiatry. 2025-01-01 - 8 citationsEfficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder.Valerie Arnold, Sonia Ancoli-Israel, Thien Thanh Dang-Vu, Kazuo Mishima, Kate Pinner
Neurology and Therapy. 2024-08-01
Journal Articles
- A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults wit...Valerie Arnold, Journal of Attention Disorders, 1/8/2014
- A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults Wit...Valerie Arnold, MD, David Feifel, Craig Earl, Ronghua Yang, Lenard Adler, Journal of Attention Disorders, 5/22/2012
- The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder in a Double-Blind, Placeb...Ann C. Childress, MD; Valerie Arnold, MD; Ben Adeyi, MS; Bryan Dirks, MD; Thomas Babcock, DO; Brian Scheckner, PharmD; Robert Lasser, MD; Frank A. Lopez, MD, Journal of Attention Disorders, 1/1/2010
Books/Book Chapters
Abstracts/Posters
- Principles of Deficit/Hyperactivity Disorder Management and Review of Clinical Trail Data on the Efficacy and Safety of Lisdexamfetamine Dimesylate, a Long-acting Prod...Jennifer Ganem, MS, APRN, Gail Ziv, NP, Thomas Babcock, Do, Ann Childress, MD, Valerie Arnold, MD, American Academy of Nurse Practioners (AANP) 27th National Conference, Orlando, FL, 6/20/2012
- Sex, Drugs and Rock’n Roll – Substance Use in AdolescentsArnold V, 10th Annual Update in Acute and Emergency Care, Le Bonheur Children’s Hospital, Memphis, TN, 10/21/2011
- The Placebo Effect in Clinical ResearchArnold V, Clinical Research Forum, St Jude Children’s Research Hospital, Memphis, TN, 1/28/2011
Press Mentions
Live at 9: ‘Do You Really Need That Pill?’, Neurofeedback & the Weight Is over Fashion ShowSeptember 18th, 2018
Committees
- Assembly Rep, American Psychiatric Association
- Assembly Rep, American Academy of Child and Adolescent Psychiatry
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









